Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,536 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,903 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03835533 | Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations(PORTER) | completed | Phase 1 | 43 | Parker Institute for Cancer ImmunotherapyOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT03148795 | A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 128 | PfizerINDUSTRY | 14 | Apr 5, 2024 |
| clinicaltrials |
| NCT05736094 | Ultrasound for Detection of Prostate Cancer(SURF) | completed | N/A | 11 | Oslo University HospitalOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT03292874 | High Resolution MRI Study for Prostate Cancer | completed | N/A | 64 | Cedars-Sinai Medical CenterOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT03650153 | Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal | completed | N/A | 165 | Princess Al-Johara Al-Ibrahim Cancer Research CenterOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05772598 | Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires(SMACS) | completed | — | 305 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT02325557 | ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) | completed | Phase 1 / Phase 2 | 50 | Advaxis, Inc.INDUSTRY | 1 | Apr 2, 2024 | clinicaltrials |
| NCT03343093 | Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors | completed | N/A | 403 | University of MinnesotaOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT04804839 | Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary Incontinence | completed | N/A | 72 | Hacettepe UniversityOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT03419585 | The "PC-LIGHT" Study | completed | N/A | 75 | Northwestern UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT02635256 | Hypofractionated Radiosurgery for Localised Prostate Cancer(HYPOSTAT) | completed | N/A | 85 | University Hospital Schleswig-HolsteinOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT03822871 | A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 | 17 | Cancer Targeted TechnologyINDUSTRY | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05252364 | A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 22 | Hinova Pharmaceuticals Aus Pty LtdINDUSTRY | 1 | Mar 21, 2024 | clinicaltrials |
| NCT03311555 | A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) | completed | Phase 2 | 39 | Andrew J. Armstrong, MDOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT00188708 | Effect of Casodex on Tumour Hypoxia - Prostate Cancer | completed | N/A | 30 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT00789607 | Fiducial Localization and Individualized Radiotherapy -Prostate Cancer(FLIP) | completed | N/A | 17 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT01759771 | Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial(VD3PCa) | completed | Phase 2 | 130 | VA Office of Research and DevelopmentFED | 1 | Mar 18, 2024 | clinicaltrials |
| NCT02034955 | Prostatectomy Adaptive Radiation Therapy (ART) | completed | N/A | 21 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT03856437 | A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination | completed | N/A | 1,170 | University of Maryland, College ParkOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT04224740 | Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer(HERCULES) | completed | Phase 2 | 37 | Latin American Cooperative Oncology GroupOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06214000 | Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney(LiVHOU) | completed | — | 178 | University Hospital, Strasbourg, FranceOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06309732 | GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)(GAMEC-II) | completed | Phase 2 | 36 | Queen Mary University of LondonOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06299046 | Bleeding After Robot-assisted Radical Prostatectomy: a Respective Study(UROBLOOD01) | completed | — | 194 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06179706 | 11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients. | completed | — | 20 | IRCCS San RaffaeleOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT02280356 | Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT01962324 | Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer(PARAPLY-1) | completed | N/A | 85 | Umeå UniversityOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT05415787 | Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.(PROMECI) | completed | — | 40 | University Hospital, ToursOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT05797727 | Real-Life Pilot Feasibility Study (LC_RLP)(LC_RLP) | completed | N/A | 121 | Aristotle University Of ThessalonikiOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT01588262 | Early Rehabilitation of Cancer Patients | completed | N/A | 300 | Haukeland University HospitalOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT03012581 | Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types(AcSé) | completed | Phase 2 | 269 | UNICANCEROTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04009174 | Multi-modality Prostate Cancer Image Guided Interventions(IGPC-2) | completed | N/A | 52 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04389918 | Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer | completed | N/A | 16 | Stanford UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05326282 | Evaluating the Role of Ultrasound in Prostate Cancer(ERUP) | completed | N/A | 100 | Hull University Teaching Hospitals NHS TrustOTHER_GOV | 1 | Feb 28, 2024 | clinicaltrials |
| NCT01423474 | Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time(PATRIOT) | completed | N/A | 152 | CancerCare ManitobaOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT03554317 | COMbination of Bipolar Androgen Therapy and Nivolumab(COMBAT-CRPC) | completed | Phase 2 | 45 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03658486 | Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial(EXACT) | completed | N/A | 30 | Queen's University, BelfastOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT03388346 | 68Ga PSMA in Preprostatectomy Patients | completed | Phase 2 / Phase 3 | 22 | Michael Graham PhD, MDOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT04786847 | 177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study(ProstACTSelect) | completed | Phase 1 | 30 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | Feb 12, 2024 | clinicaltrials |
| NCT03315260 | Treatment Satisfaction With Ra-223 in Japan | completed | — | 85 | BayerINDUSTRY | 1 | Feb 8, 2024 | clinicaltrials |
| NCT00946881 | Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 30 | Steba Biotech S.A.OTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT02903160 | Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) | completed | Phase 2 | 40 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03651271 | Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer | completed | Phase 2 | 100 | Parker Institute for Cancer ImmunotherapyOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04644822 | Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. | completed | Phase 3 | 100 | Centre for Probe Development and CommercializationOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04220983 | PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer(PRAGMA) | completed | N/A | 22 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06244680 | Super-fast 3T Prostate MRI Using High Gradient Strength and Deep Learning | completed | — | 77 | University Hospital, BonnOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06014853 | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects | completed | Phase 1 | 48 | Bukwang PharmaceuticalINDUSTRY | 1 | Feb 5, 2024 | clinicaltrials |
| NCT03878823 | Safety and Pharmacokinetics of ODM-209(STESIDES) | completed | Phase 1 / Phase 2 | 38 | Orion Corporation, Orion PharmaINDUSTRY | 3 | Feb 1, 2024 | clinicaltrials |
| NCT00099086 | Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 1 | 20 | Medical University of South CarolinaOTHER | 0 | Jan 31, 2024 | clinicaltrials |
| NCT02543255 | Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)(ACDC-RP) | completed | Phase 2 | 76 | University Health Network, TorontoOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT03698370 | Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer | completed | Phase 2 | 27 | Andrei IagaruOTHER | 1 | Jan 30, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Apr 12, 2024source: clinicaltrials